BreakthroughT1D Executive and Leadership Team

Aaron Kowalski, the Chief Executive Officer at BreakthroughT1D, directs the overarching research strategy to accelerate the development of therapies for type 1 diabetes. By prioritizing high-impact clinical trials and scientific innovation, the Chief Executive Officer ensures that the organization maintains a rigorous focus on long-term medical solutions. This leadership role involves constant collaboration with global scientific partners to translate laboratory discoveries into tangible patient outcomes. Aaron Kowalski manages the allocation of substantial research funding, ensuring that resources reach the most promising projects across international markets. Through this strategic oversight, the Chief Executive Officer strengthens the organization's position as a global leader in diabetes research. By aligning scientific goals with the needs of the community, Kowalski fosters an environment where innovation thrives, ultimately pushing the boundaries of current medical knowledge to improve patient health outcomes worldwide.

Mike Wilson, the Chief Executive Officer & Managing Director at BreakthroughT1D, oversees the operational execution of organizational goals and manages the expansion of global advocacy programs. By coordinating with government entities, the Chief Executive Officer & Managing Director secures policy changes that directly benefit the type 1 diabetes community. This role requires balancing complex administrative requirements with the urgent need for improved patient access to care. Mike Wilson drives the implementation of large-scale operational frameworks that support regional chapters and international outreach efforts. Through meticulous management of organizational resources, the Chief Executive Officer & Managing Director ensures that advocacy initiatives remain effective and scalable. Wilson maintains a focus on operational excellence, ensuring that every program aligns with the core mission of improving life for those affected by the condition. This leadership approach guarantees that the organization remains agile and responsive to evolving global health challenges.

Alan Lewis, the President & Chief Executive Officer at BreakthroughT1D, architects the long-term vision for organizational growth and community engagement. By fostering relationships with key stakeholders and donors, the President & Chief Executive Officer secures the financial foundation necessary for sustained research investment. This leadership role involves setting the strategic direction for public awareness campaigns that educate the broader population about type 1 diabetes. Alan Lewis monitors the effectiveness of community outreach programs, ensuring that individuals facing the condition receive necessary support and resources. Through consistent engagement with the Board, the President & Chief Executive Officer aligns internal operations with the broader mission of achieving a world without diabetes. Lewis drives the development of partnerships that expand the organization's reach, ensuring that the impact of these efforts remains significant across diverse geographic regions. This strategic focus ensures that the organization continues to lead in both advocacy and research.

David Mutthumani, the Chief Financial Officer at BreakthroughT1D, directs the financial planning and fiscal management of the organization to ensure the sustainability of research investments. By overseeing budget allocation and financial reporting, the Chief Financial Officer maintains the integrity of the organization's charitable funds. This role involves analyzing economic trends to optimize the distribution of resources toward the most promising research projects. David Mutthumani manages the financial health of the organization, ensuring that all operations remain compliant with regulatory standards while supporting global advocacy efforts. Through strategic financial oversight, the Chief Financial Officer provides the necessary stability for long-term projects that aim to cure type 1 diabetes. Mutthumani collaborates with the Board to align financial goals with the broader mission, ensuring that every dollar contributes to meaningful progress. This leadership role is critical for maintaining the trust of donors and the effectiveness of the organization's global operations.

Brett Stone, the Board President for Oklahoma at BreakthroughT1D, directs regional advocacy and community engagement efforts to support the organization's mission. By mobilizing local volunteers and stakeholders, the Board President for Oklahoma ensures that the needs of the regional diabetes community are represented in national policy discussions. This role involves organizing local fundraising events and awareness campaigns that contribute to the broader research goals of the organization. Brett Stone oversees the development of regional partnerships that expand the reach of educational programs and support services. Through consistent leadership, the Board President for Oklahoma fosters a strong network of advocates who are committed to driving progress in the fight against type 1 diabetes. Stone collaborates with national leadership to ensure that regional activities align with the organization's strategic priorities. This leadership role is essential for maintaining a strong grassroots presence and ensuring that the impact of the organization is felt at the local level.

Elizabeth Kerr, the Advocacy Team Chair(ATC), Research Information Volunteer (RIV), Northern Indiana Board President at BreakthroughT1D, directs regional advocacy initiatives and serves as a key liaison for research information dissemination. By leading the advocacy team, the Advocacy Team Chair(ATC), Research Information Volunteer (RIV), Northern Indiana Board President ensures that local voices influence policy decisions that impact the type 1 diabetes community. This role involves translating complex research findings into accessible information for patients and families, thereby empowering the community. Elizabeth Kerr oversees regional board operations, ensuring that local activities support the organization's overarching mission of driving toward cures. Through the coordination of volunteer efforts, the Advocacy Team Chair(ATC), Research Information Volunteer (RIV), Northern Indiana Board President strengthens the organization's grassroots impact. Kerr drives the implementation of regional strategies that increase awareness and support for research. This leadership role is vital for maintaining a well-informed and active community that contributes to the organization's global success.

Pam Morrisroe, the Chief Marketing Officer at BreakthroughT1D, directs all brand communication and public awareness strategies to amplify the organization's mission. By crafting compelling narratives, the Chief Marketing Officer ensures that the urgency of type 1 diabetes research resonates with global audiences. This role involves managing digital platforms and media relations to drive engagement and support for advocacy initiatives. Pam Morrisroe oversees the development of educational materials that empower individuals to manage their condition effectively. Through data-driven marketing campaigns, the Chief Marketing Officer optimizes outreach efforts to reach diverse demographics across international markets. Morrisroe collaborates with other executive leaders to ensure that brand messaging remains consistent with the organization's strategic goals. By leveraging modern communication channels, the Chief Marketing Officer increases visibility for critical research projects, ultimately fostering a stronger connection between the organization and the community it serves while driving sustained support for life-changing medical advancements.

Bala Balasubramanian, the Chief Information Officer at BreakthroughT1D, architects the digital infrastructure required to support global research data and community engagement platforms. By implementing secure and scalable technology solutions, the Chief Information Officer ensures that the organization can effectively manage complex datasets related to diabetes research. This role involves overseeing the integration of digital tools that facilitate communication between researchers, advocates, and the patient community. Bala Balasubramanian drives the adoption of innovative software to streamline internal operations and improve data accessibility for stakeholders. Through the management of robust IT systems, the Chief Information Officer protects sensitive information while enabling real-time collaboration across international borders. Balasubramanian ensures that the organization's technological capabilities remain at the forefront of the industry, supporting the mission through efficient data management. This leadership role is essential for maintaining the digital agility required to respond to the rapidly changing needs of the global diabetes community.

Tracy Mido, the Chief Human Resources Officer at BreakthroughT1D, directs the talent acquisition and organizational development strategies that support the mission. By fostering a culture of innovation and inclusivity, the Chief Human Resources Officer ensures that the organization attracts and retains top-tier professionals dedicated to diabetes research. This role involves managing employee engagement programs and professional development initiatives that align with the organization's strategic objectives. Tracy Mido oversees the implementation of policies that promote a healthy and productive work environment across all regional operations. Through the management of human capital, the Chief Human Resources Officer ensures that the team remains equipped to handle the complexities of global advocacy and research support. Mido collaborates with other executives to align workforce capabilities with the evolving needs of the organization. This leadership role is essential for maintaining the operational strength required to drive progress toward a world without type 1 diabetes.

Eric Shen, the Chief of Staff, T1D Fund at BreakthroughT1D, directs the operational coordination and strategic alignment of the investment arm dedicated to diabetes research. By managing the flow of information between the fund and the broader organization, the Chief of Staff, T1D Fund ensures that investment decisions remain focused on high-potential therapeutic breakthroughs. This role involves facilitating communication between investment partners and the research team to accelerate the development of new treatments. Eric Shen oversees the administrative processes that support the fund's mission, ensuring that resources are deployed efficiently to maximize impact. Through the coordination of cross-functional teams, the Chief of Staff, T1D Fund maintains a focus on achieving measurable outcomes in the medical field. Shen drives the execution of strategic initiatives that bridge the gap between venture capital and patient-centered research. This leadership role is vital for ensuring that the fund remains a catalyst for innovation in the diabetes space.